{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial Comparing Supraglottic Airway Devices in Laparoscopic Cholecystectomy"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Ninety patients aged 20-65 years, ASA Physical Status Grade 1 and 2, were randomised into three groups of 30 each"
      },
      "Participants": {
        "score": 2,
        "evidence": "Ninety patients aged 20-65 years, ASA Physical Status Grade 1 and 2, were randomised into three groups of 30 each at a tertiary care center."
      },
      "Intervention": {
        "score": 2,
        "evidence": "three supraglottic airway devices (SADs)\u2014LMA-Supreme (LMA-S), i-gel, and Baska mask"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the efficacy and safety of three supraglottic airway devices (SADs)\u2014LMA-Supreme (LMA-S), i-gel, and Baska mask\u2014in patients undergoing laparoscopic cholecystectomy."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was oropharyngeal leak pressure (OLP) measured immediately after insertion and 30 minutes during carboperitonium."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was achieved using closed sealed envelopes, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "The study was not blinded."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Ninety patients aged 20-65 years, ASA Physical Status Grade 1 and 2, were randomised into three groups of 30 each"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "OLP was significantly higher in the Baska mask group (31.61 \u00b1 4.3 cmH2O) compared to the i-gel (28.27 \u00b1 3.4 cmH2O) and LMA-S (29.42 \u00b1 3.9 cmH2O) groups (p = 0.005)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant differences in complications were observed."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: None."
      }
    },
    "total_score": 16,
    "max_score": 25
  },
  "model": "gpt-4o"
}